Celyad Competitors and Similar CompaniesClear all

Alnylam's competitors and similar companies include Moderna.

	Alnylam Alnylam is a biopharmaceutical company that develops ribonucleic acid interference (RNAi) therapeutics for hepatic porphyria, primary hyperoxaluria type 1 (PH1), cardiovascular, and polyneuropathy treatments.	Moderna Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.
Founding Date	Founding Date 2002	Founding Date 2010
Type	Type Public	Type Public
Tags	Tags Healthcare biotech pharma	Tags Healthcare biotech clinical research drug development pharma
Locations	Locations Cambridge, US HQ Paris, FR Milan, IT Tokyo, JP Amsterdam, NL Stockholm, SE Zug, CH see more	Locations Cambridge, US HQ Melbourne, AU Paris, FR München, DE Tokyo, JP Seoul, KR Warszawa, PL see more
Employees	Employees 1,32324% increase	Employees 5,8004% increase
Valuation ($)	Valuation ($) 36.5 b	Valuation ($) 21.2 b
Financial
Revenue (est.)	Revenue (est.) $3.7b (FY, 2025)	Revenue (est.) $1.9b (FY, 2025)
Cost of goods	Cost of goods $677.2m (FY, 2025)	Cost of goods $868m (FY, 2025)
Gross profit	Gross profit $3b (FY, 2025)	Gross profit $1.1b (FY, 2025)
Net income	Net income $313.7m (FY, 2025)	Net income ($2.8b) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 1.5b	Total funding raised $ 1.8b

For sources of this data, please see the company profile

Cambridge, US

Employees

5,800↑ 4% increase

Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.

Financial